The Hunt Irrevocable Trust v. Air Medical Group Holdings, LLC

CourtDistrict Court, D. Delaware
DecidedOctober 16, 2023
Docket1:21-cv-00679
StatusUnknown

This text of The Hunt Irrevocable Trust v. Air Medical Group Holdings, LLC (The Hunt Irrevocable Trust v. Air Medical Group Holdings, LLC) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
The Hunt Irrevocable Trust v. Air Medical Group Holdings, LLC, (D. Del. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

MICHAEL R. CAHILL, TRUSTEE of THE § HUNT IRREVOCABLE TRUST and of § THE HUNT LEGACY TRUST, § § Plaintiffs/Counterclaim § Defendants § § v. § Civil Action No. 21-679-WCB § AIR MEDICAL GROUP HOLDINGS, INC., § § Defendant/Counterclaim § Plaintiff. § §

MEMORANDUM OPINION AND ORDER On June 16, 2023, both parties filed motions for summary judgment in this contract action. Dkt. Nos. 63 & 64. On August 15, 2023, I granted each party’s motion in part and denied it in part. Dkt. No. 95. Defendant Air Medical Group Holdings, Inc., has now filed what it has styled as a motion for judgment on the pleadings under Federal Rule of Civil Procedure 12(c). Dkt. No. 99. The plaintiffs have filed a brief in opposition, Dkt. No. 101, and Air Medical has filed a reply, Dkt. No. 102. Although denominated a motion to dismiss, Air Medical’s motion appears to be more properly characterized as a second motion for summary judgment or an untimely motion for reconsideration. For reasons explained below, however, I do not regard the characterization of the motion as disqualifying and have therefore addressed the merits of the motion . For the following reasons, Air Medical’s motion is DENIED. I In my earlier order denying Air Medical’s motion for summary judgment in part, I held that Air Medical’s reliance in its counterclaim on a theory of indemnification under the Purchase and Sale Agreement (“the Agreement”) was time-barred by the terms of the Agreement’s indemnification article, Article IX. Section 9.01 of the Agreement provides that claims that are

governed by the indemnification article cannot be brought after the “Survival Date,” i.e., 18 months after the closing date for the Agreement. Dkt. No. 99 at 15. Based on the rationale underlying that ruling, Air Medical now contends that this lawsuit, which Hunt filed more than 18 months after the closing date for the Agreement, is also time-barred. I disagree. Air Medical treats the indemnification article of the Agreement as if it forecloses all claims by Hunt under the Agreement that are not brought within 18 months of the closing of the sales transaction. That is, Air Medical’s theory is that the 18-month limitations period applies to any claim by Hunt that Air Medical has not complied with its obligations under the Agreement.

The obligation at issue in this case, according to Hunt, is to pay over the settlement funds from the negligence action over the damage to the N5DM aircraft, funds that were ultimately paid by the insurer for the defendant in that lawsuit. Hunt argues that it is entitled to those funds because they constitute “insurance proceeds” under paragraph E-1 of the Agreement (the “Second Miscellaneous Clause”). Those insurance proceeds, according to Hunt, constituted Retained Property under the Agreement and therefore were not transferred to Air Medical as part of the sale. See Agreement § 6.06(a). Hunt contends that if those funds are regarded as “insurance proceeds,’ within the meaning of the Second Miscellaneous Clause, Air Medical was required to remit them to Hunt when Air Medical received those proceeds at the conclusion of the negligence litigation in 2020. Hunt’s reasoning is that its claim is not one for indemnification, but for breach of the contract obligations, and that the 18-month limitations period set forth in the indemnification article of the Agreement does not apply to Hunt’s present claim. The text of the Agreement is consistent with Hunt’s ultimate conclusion. The various sections of Article IX of the Agreement, which is denominated “Indemnification,” raise the

question whether the provisions of that article apply to an obligation such as the one at issue in this case, i.e., an obligation that allegedly arose after the closing of the sales transaction. But reading the various provisions of Article IX together, it is apparent that the 18-month period does not apply to all claims arising under the Agreement, and in particular the 18-month period does not apply to a claim such as Hunt’s, which arose both after the closing and after the 18-month post- closing period had ended. Section 9.01 of Article IX states that, as a general matter, “the representations, warranties, covenants and agreements set forth in this Agreement shall survive the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby until the Survival

Date and shall thereafter be of no further force or effect.” Section 9.01 initially defines the Survival Date to mean the 18-month anniversary of the closing date for the sale transaction. However, section 9.01 then sets out various exceptions to that 18-month limitations period for asserting claims under the Agreement. It provides that certain obligations set forth in the Agreement shall survive until 60 days after the expiration of the applicable statute of limitations; that certain other obligations shall survive until the 36-month anniversary of the closing date; and that “each other covenant and agreement of any party which by their terms are to be performed or observed following the Closing shall survive the Closing until fully performed or observed in accordance with their terms.” Agreement, § 9.01. Section 9.01 further provides that no claim for “indemnification for breach of any representation, warranty, covenant or agreement” contained in the Agreement may be asserted unless, prior to the Survival Date, the claim is asserted by written notice to the other party. That provision, however, expressly does not apply to any covenant or agreement “which by its terms is to be performed or observed following the Closing.” Id.

Section 9.08 of Article IX provides that the “obligations to indemnify and hold harmless an Indemnitee in respect of a breach of representation, warranty, covenant or agreement shall terminate on the Survival Date with respect to such representation, warranty, covenant or agreement, and no claim for indemnification hereunder may be made after the expiration of such Survival Date,” unless the indemnitee has made a claim relating to such a covenant pursuant to section 9.01 prior to the Survival Date. The “survival date,” for purposes of section 9.08, refers back to the definition of “survival date” in section 9.01. Section 9.10 of Article IX provides that the rights to indemnification under Article IX “shall constitute the sole and exclusive right and remedy available to the [buyer and seller] for any

and all losses or other claims relating to or arising from breaches of this agreement prior to closing and the transactions contemplated hereby to occur prior to closing.” Reading the sections of Article IX together leads to several important conclusions relevant to the parties’ positions in the instant motion. First, as section 9.01 makes clear, the 18-month “survival date” for indemnification claims does not apply to any agreement that by its terms is to be performed or observed following the closing. Second, the “written notice” requirement of section 9.01 also does not apply to such agreements. Third, section 9.10 confirms the limited scope of the 18-month limitation period by stating that the right to indemnification set forth in Article IX constitutes the sole and exclusive right and remedy to the parties for all claims “arising from breaches of this Agreement prior to closing.” (emphasis added). In light of the clear exclusion of claims directed to post-closing breaches in sections 9.01 and 9.10, it is apparent that section 9.08, on which Air Medical heavily relies, applies only to those agreements not excluded from the coverage of Article IX by sections 9.01 and 9.10. That is,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pharmacy Benefit Managers Antitrust Litigation
582 F.3d 432 (Third Circuit, 2009)
Williams v. Runyon
130 F.3d 568 (Third Circuit, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
The Hunt Irrevocable Trust v. Air Medical Group Holdings, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/the-hunt-irrevocable-trust-v-air-medical-group-holdings-llc-ded-2023.